MoneyWorks4Me

Cipla reports 18% rise in Q1 consolidated net profit

29 Jul 2024 Evaluate

Cipla has reported results for first quarter ended June 30, 2024 (Q1FY25). 

The company has reported 17.98% rise in net profit at Rs 1,055.94 crore for Q1FY25 as compared to Rs 895.02 crore for the same quarter in the previous year. Total income of the company increased by 15.56% at Rs 4,714.57 crore for Q1FY25 as compared to Rs 4,079.88 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 17.77% rise in its net profit at Rs 1,175.46 crore for the quarter ended June 30, 2024 as compared to Rs 998.07 crore for the same quarter in the previous year. Total income of the company increased by 6.02% at Rs 6,854.13 crore for Q1FY25 as compared to Rs 6,465.18 crore for the corresponding quarter previous year.


Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..